As of Q3'25, CVS's latest Return on Sales (ROS) stands at -2.61%, marking a significant decline from the previous quarter's 2.44%. This negative value indicates that the company experienced an operating loss relative to its sales during this period. Over the period from Q1'23 to Q3'25, CVS's ROS has exhibited notable volatility, fluctuating between a high of 4.13% in Q3'23 and the recent low of -2.61% in Q3'25. After a relatively stable performance in 2023, the metric saw a sharp drop in Q1'24, partial recovery in Q2'24, and another dip in Q3'24. The most recent quarters highlight increased instability, culminating in the first negative ROS in the observed timeframe, signaling potential operational challenges.